ImmuneOncia aims to develop immuno-oncology therapeutics

to transform the standard of care in cancer treatment

  • IR/PR
  • Disclosures

Disclosures

Submission Date Disclosure Title Author
2025-04-17 [Corrected description]Registration Statement (Equity securities) 이뮨온시아
2025-04-04 [Corrected attachment]Registration Statement (Equity securities) 이뮨온시아
2025-04-04 [Corrected description]Registration Statement (Equity securities) 이뮨온시아
2025-04-02 [Corrected description]Registration Statement (Equity securities) 이뮨온시아
2025-03-28 Audit report (2024.12) 삼일회계법인
2025-03-14 Registration Statement (Equity securities) 이뮨온시아
2024-04-08 Audit report (2023.12) 삼일회계법인
2023-03-30 Audit report (2022.12) 한영회계법인
2022-03-30 Audit report (2021.12) 한영회계법인
1 2